Large, long-term study shows dutasteride reduced prostate cancer risk in men at increased risk of the disease

GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment

GE HealthCare and Mayo Clinic have launched the MI-BET research collaboration, a theranostics study aimed at developing a more personalized

Llamar al cáncer de próstata de bajo riesgo de otra forma podría salvar más vidas, argumentan investigadores

Water Vapor Therapy Clears Prostate Cancer in 75% of Men in Early Trial

A subset analysis of an ongoing prospective study across 19 sites evaluated water vapor therapy (transurethral ablation) for intermediate-ri

Large Analysis Links Low Testosterone to Higher Cancer Mortality Risk in Men

A large international analysis of 11 long-running studies involving over 26,000 men found that very low testosterone levels are associated w

Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis

177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial